Madrigal Pharmaceuticals Inc (MDGL) — Capital Reinvestment Ratio

Latest as of September 2025: 0.01x

Madrigal Pharmaceuticals Inc (MDGL) has a Capital Reinvestment Ratio of 0.01x as of September 2025, meaning it reinvests 0% of its operating cash flow ($79.85 Million) in capital expenditures ($857.00K). See how leveraged is Madrigal Pharmaceuticals Inc's balance sheet to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

$79.85 Million
USD

Capital Expenditures

$857.00K
USD

Data as of

Sep 2025
Most recent filing

Madrigal Pharmaceuticals Inc Capital Reinvestment Ratio (2007–2007)

This chart tracks Madrigal Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. Check MDGL total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Madrigal Pharmaceuticals Inc (2007–2007)

Year-by-year Capital Reinvestment Ratio for Madrigal Pharmaceuticals Inc from 2007 to 2007. For live market cap and broader valuation context, see market cap of Madrigal Pharmaceuticals Inc.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2007 0.09x $27.22 Million $2.35 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow